Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Transitional cell cancer of the renal pelvis and ureter+1

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Padeliporfin Therapy for Patients with Low-Grade Upper Tract Urothelial Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Padeliporfin

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Glofitamab with R-CHOP for High-Risk Patients with Untreated Diffuse Large B-Cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Mantle cell lymphoma

Not recruiting

Registered drugNo placebo

Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Non-Hodgkin's lymphoma+13

Not recruiting

InvestigationalNo placebo

Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tazemetostat

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Selpercatinib

Contact Research Centre

Uveitis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Baricitinib

Contact Research Centre

Macular telangiectasia

Not recruiting

Registered drugNo placebo

Study Comparing Aflibercept and Placebo for Patients with Macular Telangiectasia Type 1

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Aflibercept

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Chronic cutaneous lupus erythematosus

Not recruiting

Investigational

Study of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus

Investigational

France

Participants:18–64 years · 65+ years
Substances:Daxdilimab

Contact Research Centre

Find therapies in clinical trials near you – page 46

641 trials match your criteria

Hidradenitis

Study on the Effectiveness of Ianalumab for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

Dermatitis atopic

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Hidradenitis

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Transitional cell cancer of the renal pelvis and ureter+1

Study on the Safety and Effectiveness of Padeliporfin Therapy for Patients with Low-Grade Upper Tract Urothelial Cancer

Diffuse large B-cell lymphoma

Study on the Safety and Effectiveness of Glofitamab with R-CHOP for High-Risk Patients with Untreated Diffuse Large B-Cell Lymphoma

Mantle cell lymphoma

Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

Non-Hodgkin's lymphoma+13

Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

Non-small cell lung cancer

Study of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment

Uveitis

Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

Macular telangiectasia

Study Comparing Aflibercept and Placebo for Patients with Macular Telangiectasia Type 1

Dermatitis atopic

Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

Chronic cutaneous lupus erythematosus

Study of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.